1887

Abstract

To evaluate whether the detection of DNA in CSF could contribute to the differential diagnosis of AIDS-related focal brain lesions, CSF samples from 88 HIV-infected patients (56 with focal brain lesions and 32 without) were tested prospectively by a nested PCR for the B1 gene of . The assay had a detection limit of 10 trophozoite equivalents. Six of 18 patients with toxoplasmic encephalitis, but none of the 70 patients with other disorders, were PCR-positive (33.3% sensitivity and 100% specificity). Considering only those patients with cerebral toxoplasmosis from whom CSF was collected before or during the first week of antitoxoplasmic therapy, sensitivity rose to 50%. This was higher than the sensitivity in patients whose CSF was collected after the first week of treatment (odds ratio (OR) of 7.0; 95% CI: 0.46-218.2). The administration of antitoxoplasmic prophylaxis did not affect the PCR results. Patients with a poor response to therapy had a higher probability of detectable DNA in their CSF (OR of 5.0; 95% CI: 0.37-86.6). All patients with other central nervous system disorders were PCR-negative. Despite the moderate sensitivity, the high specificity and positive predictive value (100%) make this assay a useful tool in the differential diagnosis of AIDS-related focal brain lesions as part of a series of CSF and neuroradiological examinations.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-45-6-472
1996-12-01
2022-10-04
Loading full text...

Full text loading...

/deliver/fulltext/jmm/45/6/medmicro-45-6-472.html?itemId=/content/journal/jmm/10.1099/00222615-45-6-472&mimeType=html&fmt=ahah

References

  1. Bacellar H., Munoz A., Miller E. N. Temporal trends in the incidence of HIV-1-related neurologic diseases. Multicenter AIDS cohort study, 1985-1992. Neurology 1994; 44:1892–1900
    [Google Scholar]
  2. Centers for Disease Control 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41:(RR17)1–19
    [Google Scholar]
  3. Girard P.-M., Landman R., Gaudebout C. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328:1514–1520
    [Google Scholar]
  4. Antinori A., Murri R., Ammassari A. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS 1995; 9:1343–1350
    [Google Scholar]
  5. Grover C. M., Thulliez P., Remington J. S., Boothroyd J. C. Rapid prenatal diagnosis of congenital toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 1990; 28:2297–2301
    [Google Scholar]
  6. Weiss L. M., Udem S. A., Salgo M., Tanowitz H. B., Wittner M. Sensitive and specific detection of toxoplasma DNA in an experimental murine model: use of T. gonJ/7-specific cDNA and the polymerase chain reaction. J Infect Dis 1991; 163:180–186
    [Google Scholar]
  7. Bretagne S., Costa J.-M., Fleury-Feith J., Poron F., Dubreuil-Lemaire M.-L., Vidaud M. Quantitative competitive PCR with bronchoalveolar lavage fluid for diagnosis of toxoplasmosis in AIDS patients. J Clin Microbiol 1995; 33:1662–1664
    [Google Scholar]
  8. Verhofstede C., Reniers S., Colebunders R., van Wanzeele F., Plum J. Polymerase chain reaction in the diagnosis of Toxoplasma encephalitis. AIDS 1993; 7:1539–1541
    [Google Scholar]
  9. Schoondermark-van de Ven E., Galama J., Kraaijeveld C., van Druten J., Meuwissen J., Melchers W. Value of polymerase chain reaction for the detection of Toxoplasma gondii in cerebrospinal fluid from patients with AIDS. Clin Infect Dis 1993; 16:661–666
    [Google Scholar]
  10. Novati R., Castagna A., Morsica G. Polymerase chain reaction for Toxoplasma gondii DNA in cerebrospinal fluid of AIDS patients with focal brain lesions. AIDS 1994; 8:1691–1694
    [Google Scholar]
  11. Dupon M., Cazenave J., Pellegrin J. –L. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol 1995; 33:2421–2426
    [Google Scholar]
  12. Eggers C., Gross U., Klinker H., Schalke B., Stellbrink H. J., Kunze K. Limited value of ■ cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol 1994; 242:644–649
    [Google Scholar]
  13. De Luca A., Cingolani A., Linzalone A. Improved detection of JC virus DNA in cerebrospinal fluid for the diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Microbiol 1996; 34:1343–1346
    [Google Scholar]
  14. De Luca A., Antinori A., Cingolani A. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995; 90:844–849
    [Google Scholar]
  15. Aurelius E., Johansson B., Skoldenberg B., Staland A., Forsgren M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 1991; 337:189–192
    [Google Scholar]
  16. Lebech M., Lebech A.-M., Nelsing S., Vuust J., Mathiesen L., Petersen E. Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from AIDS patients with cerebral toxoplasmosis. J Infect Dis 1992; 165:982–983
    [Google Scholar]
  17. Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning: a laboratory manual. 2nd edn Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 1989
    [Google Scholar]
  18. Sackett D. L., Haynes R. B., Guyatt G. H., Tugwell P. The interpretation of diagnostic data. In: Clinical epidemiology. A basic science for clinical medicine. 2nd edn Boston: Little Brown and Company; 199169–152
    [Google Scholar]
  19. Ammassari A., Murri R., Cingolani A., De Luca A., Antinori A. AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment. Curr Top Microbiol Immunol 1996 (in press)
    [Google Scholar]
  20. Mathews C., Barba D., Fullerton S. C. Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS 1995; 9:1243–1250
    [Google Scholar]
  21. Forsyth P. A., Yahalom J., DeAngelis L. M. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994; 44:1473–1479
    [Google Scholar]
  22. Pierce M. A., Johnson M. D., Maciunas R. J. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 1995; 123:594–598
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-45-6-472
Loading
/content/journal/jmm/10.1099/00222615-45-6-472
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error